Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

NCT04595136 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV-2 Infection

Interventions

DRUG: Drug COVID19-0001-USR
DRUG: normal saline

Sponsor

United Medical Specialties